Ad
related to: myapps usoncology open space system for employees log in online
Search results
Results From The WOW.Com Content Network
x. AOL works best with the latest versions of the browsers. You're using an outdated or unsupported browser and some AOL features may not work properly.
Oncology Information System (OIS) is a software solution that manages departmental, administrative and clinical activities in cancer care. It aggregates information into a complete oncology -specific electronic health record to support medical information management.
Created by members of ASCO, the Conquer Cancer Foundation of ASCO is a 501(c)(3) charitable organization. Since the inception of its grants and awards program in 1984, Conquer Cancer has awarded more than $90 million in funding through nearly 1,500 grants and awards to researchers in 65 countries.
Spacelabs Healthcare [1] is an American manufacturer of medical equipment and is a wholly owned subsidiary of OSI Systems (Nasdaq: OSIS) of Hawthorne, California and offers products and services from two divisions: patient monitoring and connectivity and diagnostic cardiology.
The credit management system helps to ensure that users are returning results which are both statistically and scientifically accurate. Online volunteer computing is a complicated and variable mix of long-term users, retiring users and new users with different personal aspirations.
The Aerospace Corporation, as the FFRDC for national security space, primarily supports the United States Space Force's Space Systems Command as well as the National Reconnaissance Office. Their 50-year history working side by side with these organizations has made Aerospace the national memory and data repository for launch and satellite systems.
In 2019, JTCC received approval from the National Cancer Institute (NCI) as a member of the NCI-approved Georgetown Lombardi Comprehensive Cancer Center. [6] The partnership focuses on advancing research and treatment in breast cancer, cancer prevention and control, experimental therapeutics and molecular oncology.
McKesson would acquire about a 70% stake in the unit, which would be part of its U.S. pharmaceutical segment. Upon the close of the transaction, Florida Cancer Specialists — which operates in ...